Publications

  1. Wong KL, Taner T, Smith BH, Kushwaha SS, Edwards BS, Gandhi MJ, Kremers WK, Daly RC, Pereira NL. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation. Circulation 2017 Oct 03; 136 (14):1350-1352
    View PubMed
  2. Luzum JA, Pakyz RE, Elsey AR, Haidar CE, Peterson JF, Whirl-Carrillo M, Handelman SK, Palmer K, Pulley JM, Beller M, Schildcrout JS, Field JR, Weitzel KW, Cooper-DeHoff RM, Cavallari LH, O'Donnell PH, Altman RB, Pereira N, Ratain MJ, Roden DM, Embi PJ, Sadee W, Klein TE, Johnson JA, Relling MV, Wang L, Weinshilboum RM, Shuldiner AR, Freimuth RR, Pharmacogenomics Research Network Translational Pharmacogenetics Program. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems. Clin Pharmacol Ther. 2017 Sep; 102 (3):502-510 Epub 2017 June 09
    View PubMed
  3. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Renal Allograft Outcome After Simultaneous Heart and Kidney Transplantation. Am J Cardiol. 2017 Aug 01; 120 (3):494-499 Epub 2017 May 11
    View PubMed
  4. Luis SA, Maleszewski JJ, Young PM, Schaff HV, Pereira NL. Previously Unreported in Women Galactosidase Alpha Pro409Ser Variant Is Associated With Fabry Disease. Circ Cardiovasc Genet. 2017 Aug; 10 (4):e001661
    View PubMed
  5. Hasin T, Grupper A, Dillon JJ, Maleszewski JJ, Li Z, Topilsky Y, Frantz RP, Edwards BS, Pereira NL, Maltais S, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year. ASAIO J. 2017 Jul/Aug; 63 (4):401-407
    View PubMed
  6. Arendt CJ, Hong JH, Daly RC, Scott C, Mehta RA, Bailey K, Pathak J, Pereira NL. Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery. Am Heart J. 2017 May; 187:70-77.
    View PubMed
  7. de Denus S, Rouleau JL, Mann DL, Huggins GS, Pereira NL, Shah SH, Cappola TP, Fouodjio R, Mongrain I, Dube MP. CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. Pharmacogenomics J. 2017 Apr 25;
    View PubMed
  8. Snipelisky D, Park JY, Lerman A, Mulvagh S, Lin G, Pereira N, Rodriguez-Porcel M, Villarraga HR, Herrmann J. How to Develop a Cardio-Oncology Clinic. Heart Fail Clin. 2017 Apr; 13 (2):347-359
    View PubMed
  9. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation. J Heart Lung Transplant. 2017 Mar; 36: (3)297-304.
    View PubMed
  10. Nestorovic EM, Grupper A, Joyce LD, Milic NM, Stulak JM, Edwards BS, Pereira NL, Daly RC, Kushwaha SS. Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes. Am J Cardiol. 2017 Feb 01; 119: (3)452-456.
    View PubMed
  11. Simha V, Qin S, Shah P, Smith BH, Kremers WK, Kushwaha S, Wang L, Pereira NL. Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients. J Cardiovasc Transl Res. 2017 Feb; 10: (1)9-15.
    View PubMed
  12. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant. 2016 Dec; 16: (12)3522-3531.
    View PubMed
  13. Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction. JACC Heart Fail. 2016 Nov; 4: (11)847-856.
    View PubMed
  14. Kiernan MS, Sundareswaran KS, Pham DT, Kapur NK, Pereira NL, Strueber M, Farrar DJ, DeNofrio D, Rogers JG. Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy. J Card Fail. 2016 Oct; 22: (10)797-805.
    View PubMed
  15. Grupper A, Nestorovic EM, Daly RC, Milic NM, Joyce LD, Stulak JM, Joyce DL, Edwards BS, Pereira NL, Kushwaha SS. Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience. Transplant Direct. 2016 Oct; 2 (10):e106 Epub 2016 Sept 13
    View PubMed
  16. Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, Merlo M. Myocarditis in Clinical Practice. Mayo Clin Proc. 2016 Sep; 91: (9)1256-66.
    View PubMed
  17. Grupper A, Zhao YM, Sajgalik P, Joyce LD, Park SJ, Pereira NL, Stulak JM, Burnett JC Jr, Edwards BS, Daly RC, Kushwaha SS, Schirger JA. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation. Am J Cardiol. 2016 Jun 01; 117: (11)1765-70.
    View PubMed
  18. Fine NM, Park SJ, Stulak JM, Topilsky Y, Daly RC, Joyce LD, Pereira NL, Schirger JA, Edwards BS, Lin G, Kushwaha SS. Proximal thoracic aorta dimensions after continuous-flow left ventricular assist device implantation: Longitudinal changes and relation to aortic valve insufficiency. J Heart Lung Transplant. 2016 Apr; 35: (4)423-32.
    View PubMed
  19. Taslimitehrani V, Dong G, Pereira NL, Panahiazar M, Pathak J. Developing EHR-driven heart failure risk prediction models using CPXR(Log) with the probabilistic loss function. J Biomed Inform. 2016 Apr; 60:260-9.
    View PubMed
  20. Pereira NL, Geske JB, Mayr M, Shah SH, Rihal CS. Pharmacogenetics of Clopidogrel: An Unresolved Issue. Circ Cardiovasc Genet. 2016 Apr; 9 (2):185-8
    View PubMed
  21. Bielinski SJ, Pathak J, Carrell DS, Takahashi PY, Olson JE, Larson NB, Liu H, Sohn S, Wells QS, Denny JC, Rasmussen-Torvik LJ, Pacheco JA, Jackson KL, Lesnick TG, Gullerud RE, Decker PA, Pereira NL, Ryu E, Dart RA, Peissig P, Linneman JG, Jarvik GP, Larson EB, Bock JA, Tromp GC, de Andrade M, Roger VL. A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network. J Cardiovasc Transl Res. 2015 Nov; 8: (8)475-83.
    View PubMed
  22. Pereira NL, Sargent DJ, Farkouh ME, Rihal CS. Genotype-based clinical trials in cardiovascular disease. Nat Rev Cardiol. 2015 Aug; 12: (8)475-87.
    View PubMed
  23. Grupper A, Park SJ, Pereira NL, Schettle SD, Gerber Y, Topilsky Y, Edwards BS, Daly RC, Stulak JM, Joyce LD, Kushwaha SS. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease. J Heart Lung Transplant. 2015 Aug; 34: (8)1042-9.
    View PubMed
  24. Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Chai Y, Olson TM, Rodeheffer RJ, Redfield MM, Weinshilboum RM, Burnett JC. Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites. Circ Cardiovasc Genet. 2015 Feb; 8: (1)141-9.
    View PubMed
  25. Panahiazar M, Taslimitehrani V, Pereira NL, Pathak J. Using EHRs for Heart Failure Therapy Recommendation Using Multidimensional Patient Similarity Analytics. Stud Health Technol Inform. 2015; 210:369-73.
    View PubMed
  26. Panahiazar M, Taslimitehrani V, Pereira N, Pathak J. Using EHRs and Machine Learning for Heart Failure Survival Analysis. Stud Health Technol Inform. 2015; 216:40-4.
    View PubMed
  27. Hasin T, Kushwaha SS, Lesnick TG, Kremers W, Boilson BA, Schirger JA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Jaffe AS. Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure. Am J Cardiol. 2014 Oct 15; 114: (8)1257-63.
    View PubMed
  28. Hasin T, Huebner M, Li Z, Brown D, Stulak JM, Boilson BA, Joyce L, Pereira NL, Kushwaha SS, Park SJ. Association of HeartMate II left ventricular assist device flow estimate with thermodilution cardiac output. ASAIO J. 2014 Sep-Oct; 60(5):513-8.
    View PubMed
  29. Dunlay SM, Allison TG, Pereira NL. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation. J Card Fail. 2014 Aug; 20: (8)548-54.
    View PubMed
  30. Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL. The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation. 2014 Jul 27; 98: (2)229-38.
    View PubMed
  31. Schettle SD, Pruthi RK, Pereira NL. Continuous-flow left ventricular assist devices and gastrointestinal bleeding: potential role of danazol. J Heart Lung Transplant. 2014 May; 33(5):549-50. Epub 2014 Feb 4
    View PubMed
  32. Dunlay SM, Pereira NL, Kushwaha SS. Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc. 2014 May; 89: (5)662-76.
    View PubMed
  33. Suresh R, Grogan M, Maleszewski JJ, Pellikka PA, Hanna M, Dispenzieri A, Pereira NL. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr. 2014 Apr; 27: (4)440-7.
    View PubMed
  34. Hasin T, Deo S, Maleszewski JJ, Topilsky Y, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Kushwaha SS, Park SJ. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014 Jan-Feb; 60(1):9-14.
    View PubMed
  35. Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, Rodeheffer RJ, Burnett JC Jr. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. PLoS One. 2014; 9: (1)e85708.
    View PubMed
  36. Liang JJ, Geske JR, Boilson BA, Frantz RP, Edwards BS, Kushwaha SS, Kremers WK, Weinshilboum RM, Pereira NL. TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation. Pharmacogenet Genomics. 2013 Dec; 23: (12)658-65.
    View PubMed
  37. Fine NM, Topilsky Y, Oh JK, Hasin T, Kushwaha SS, Daly RC, Joyce LD, Stulak JM, Pereira NL, Boilson BA, Clavell AL, Edwards BS, Park SJ. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013 Nov; 6: (11)1129-40.
    View PubMed
  38. Shankar N, Daly R, Geske J, Kushwaha SK, Timmons M, Joyce L, Stulak J, Gandhi M, Kremers W, Park S, Pereira NL. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation. 2013 Aug 15; 96(3):324-30.
    View PubMed
  39. Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE, Pharmacogenomics Research Network Translational Pharmacogenetics Program Group, Shuldiner AR, Vesely M, Robinson SW, Ambulos N Jr, Stass SA, Kelemen MD, Brown LA, Pollin TI, Beitelshees AL, Zhao RY, Pakyz RE, Palmer K, Alestock T, O'Neill C, Maloney K, Branham A, Sewell D, Relling MV, Crews K, Hoffman J, Cross S, Haidar C, Baker D, Hicks JK, Bell G, Greeson F, Gaur A, Reiss U, Huettel A, Cheng C, Gajjar A, Pappo A, Howard S, Hudson M, Pui CH, Jeha S, Evans WE, Broeckel U, Altman RB, Gong L, Whirl-Carrillo M, Klein TE, Sadee W, Manickam K, Sweet KM, Embi PJ, Roden D, Peterson J, Denny J, Schildcrout J, Bowton E, Pulley J, Beller M, Mitchell J, Danciu I, Price L, Pereira NL, Weinshilboum R, Wang L, Johnson JA, Nelson D, Clare-Salzler M, Elsey A, Burkley B, Langaee T, Liu F, Nessl D, Dong HJ, Lesko L, Freimuth RR, Chute CG. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther. 2013 Aug; 94(2):207-10. Epub 2013 Mar 19.
    View PubMed
  40. Maleszewski JJ, Murray DL, Dispenzieri A, Grogan M, Pereira NL, Jenkins SM, Judge DP, Caturegli P, Vrana JA, Theis JD, Dogan A, Halushka MK. Relationship between monoclonal gammopathy and cardiac amyloid type. Cardiovasc Pathol. 2013 May-Jun; 22(3):189-94. Epub 2012 Oct 24.
    View PubMed
  41. Pereira NL, Lin D, Pelleymounter L, Moon I, Stilling G, Eckloff BW, Wieben ED, Redfield MM, Burnett JC Jr, Yee VC, Weinshilboum RM. Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation. Circ Cardiovasc Genet. 2013 Apr; 6: (2)201-10.
    View PubMed
  42. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  43. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95: (2)389-96.
    View PubMed
  44. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15; 61(2):153-63. Epub 2012 Dec 05.
    View PubMed
  45. McKie PM, McCully RB, Kamath PS, Bower TC, McKusick MA, Lapyere AC, Pereira NL. Amelioration of high cardiac output and pulmonary hypertension by occlusion of congenital porto-systemic shunt. Circulation. 2012 Nov 20; 126(21):2533-4.
    View PubMed
  46. Hasin T, Topilsky Y, Kremers WK, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Stulak JM, Kushwaha SS, Park SJ, Pereira NL. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012 Nov 1; 110: (9)1322-8.
    View PubMed
  47. Cho YH, Deo SV, Schirger JA, Pereira NL, Stulak JM, Park SJ. Implantation of a HeartMate II left ventricular assist device via left thoracotomy. Ann Thorac Surg. 2012 Nov; 94(5):1712-4.
    View PubMed
  48. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012 Feb 07; 125: (5)708-20.
    View PubMed
  49. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan 3; 59(1):26-36.
    View PubMed
  50. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  51. Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging. 2011 Nov; 4: (6)648-61.
    View PubMed
  52. Raichlin E, Al-Omari MA, Hayes CL, Edwards BS, Frantz RP, Boilson BA, Clavell AL, Rodeheffer RJ, Schirger JA, Kushwaha SS, Allison TG, Pereira NL. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant. 2011 Oct; 30(10):1153-60. Epub 2011 May 31.
    View PubMed
  53. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF Jr, Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011 Jul 7; 365(1):32-43.
    View PubMed
  54. Saleh HK, Villarraga HR, Kane GC, Pereira NL, Raichlin E, Yu Y, Koshino Y, Kushwaha SS, Miller FA Jr, Oh JK, Pellikka PA. Normal left ventricular mechanical function and synchrony values by speckle-tracking echocardiography in the transplanted heart with normal ejection fraction. J Heart Lung Transplant. 2011 Jun; 30: (6)652-8.
    View PubMed
  55. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  56. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011 May; 4(3):266-75. Epub 2011 Feb 08.
    View PubMed
  57. Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011 Mar; 4: (3)211-22.
    View PubMed
  58. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A, Consensus Conference Participants. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011 Mar; 30(3):252-69.
    View PubMed
  59. Topilsky Y, Oh JK, Atchison FW, Shah DK, Bichara VM, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr. 2011 Feb; 24: (2)157-69.
    View PubMed
  60. Pereira NL, Aksoy P, Moon I, Peng Y, Redfield MM, Burnett JC Jr, Wieben ED, Yee VC, Weinshilboum RM. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation. J Mol Cell Cardiol. 2010 Nov; 49: (5)864-74.
    View PubMed
  61. Sareyyupoglu B, Boilson BA, Durham LA, McGregor CG, Daly RC, Redfield MM, Edwards BS, Frantz RP, Pereira NL, Park SJ. B-type natriuretic peptide levels and continuous-flow left ventricular assist devices. ASAIO J. 2010 Nov-Dec; 56(6):527-31.
    View PubMed
  62. Pereira NL, Chen D, Kushwaha SS, Park SJ. Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2010 Oct; 11: (4)503-5.
    View PubMed
  63. Pereira NL, Park SJ, Daly RC, Kushwaha SS, Edwards WD. De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant. Ann Thorac Surg. 2010 Oct; 90(4):1345-7.
    View PubMed
  64. Pereira NL, Weinshilboum RM. Cardiovascular pharmacogenomics and individualized drug therapy. Nat Rev Cardiol. 2009 Oct; 6: (10)632-8.
    View PubMed
  65. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88(2):219-25.
    View PubMed
  66. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009 Apr; 28(4):320-7.
    View PubMed
  67. Raichlin E, Villarraga HR, Chandrasekaran K, Clavell AL, Frantz RP, Kushwaha SS, Rodeheffer RJ, McGregor CG, Daly RC, Park SJ, Kremers WK, Edwards BS, Pereira NL. Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant. 2009 Jan; 9(1):132-9. Epub 2008 Nov 27.
    View PubMed
  68. Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, Pereira NL, Rodeheffer RJ, Daly RC, McGregor CG, Edwards BS, Kushwaha SS. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008 Nov 27; 86: (10)1395-400.
    View PubMed
  69. Murray DL, Pereira NL, Miller DV. An unusual presentation of post-transplant lymphoproliferative disorder mimicking vasculitis in heart transplantation. J Heart Lung Transplant. 2008 Nov; 27(11):1257-61.
    View PubMed
  70. Boilson BA, Miller DV, Pereira NL. Late allograft failure after heart transplantation: 2 unusual cases. J Heart Lung Transplant. 2008 Sep; 27(9):1050-4. Epub 2008 Jul 26.
    View PubMed
  71. Uber WE, Self SE, Van Bakel AB, Pereira NL. Acute antibody-mediated rejection following heart transplantation. Am J Transplant. 2007 Sep; 7(9):2064-74. Epub 2007 Jul 05.
    View PubMed
  72. Patel C, Shirali G, Pereira N. Left ventricular noncompaction mimicking peripartum cardiomyopathy. J Am Soc Echocardiogr. 2007 Aug; 20(8):1009.e9-12. Epub 2007 Jun 06.
    View PubMed
  73. Goodroe R, Bonnema DD, Lunsford S, Anderson P, Ryan-Baille B, Uber W, Ikonomidis J, Crumbley AJ, VanBakel A, Zile MR, Pereira N. Severe left ventricular hypertrophy 1 year after transplant predicts mortality in cardiac transplant recipients. J Heart Lung Transplant. 2007 Feb; 26(2):145-51.
    View PubMed
  74. Pereira NL, Zile MR, Harley RA, Van Bakel AB. Myocardial mechanisms causing heart failure early after cardiac transplantation. Transplant Proc. 2006 Nov; 38(9):2999-3003.
    View PubMed
  75. Craig M, Pereira NL. Right heart catheterization and risk stratification in advanced heart failure. Curr Heart Fail Rep. 2006 Sep; 3(3):143-52.
    View PubMed
  76. Baker GH, Pereira NL, Hlavacek AM, Chessa K, Shirali G. Transthoracic real-time three-dimensional echocardiography in the diagnosis and description of noncompaction of ventricular myocardium. Echocardiography. 2006 Jul; 23(6):490-4.
    View PubMed
  77. Crumbley AJ 3rd, Odom S, Van Bakel AB, Pereira N, Ikonomidis JS, Bradley S, Kratz JM, Sade RM, Uber W, Stroud MR, Crawford FA Jr. Cardiac transplantation in South Carolina: 300 transplants. J S C Med Assoc PMID 16704179. 2006 Feb; 102: (1)5-10.
  78. Peura JL, Zile MR, Feldman DS, VanBakel AB, McClure C, Uber W, Haynes H, Pereira NL. Effects of conversion from cyclosporine to tacrolimus on left ventricular structure in cardiac allograft recipients. J Heart Lung Transplant. 2005 Nov; 24(11):1969-72.
    View PubMed
  79. Siachos T, Vanbakel A, Feldman DS, Uber W, Simpson KN, Pereira NL. Silent strokes in patients with heart failure. J Card Fail. 2005 Sep; 11(7):485-9.
    View PubMed
  80. Uber WE, Uber LA, VanBakel AB, Crumbley AJ 3rd, Pereira NL, Ikonomidis JS, Feldman DS. CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications. Transplant Proc. 2004 Dec; 36(10):3245-9.
  81. Aziz TA, Pereira NL. Electrocardiographic changes simulating a myocardial infarction after cardiac transplantation. J Heart Lung Transplant. 2004 Nov; 23(11):1301-3.
    View PubMed
  82. Feldman DS, Ikonomidis JS, Uber WE, Van Bakel AB, Pereira NL, Crumbley AJ 3rd, Tann SM. Human B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery. J Card Fail. 2004 Aug; 10(4):292-6.
    View PubMed
  83. Lepore JJ, Maroo A, Pereira NL, Ginns LC, Dec GW, Zapol WM, Bloch KD, Semigran MJ. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol. 2002 Sep 15; 90(6):677-80.
    View PubMed
  84. Wood DE, Crumbley AJ, Pereira NL. Reversible left ventricular dysfunction simulating a myocardial infarction after pericardiectomy. Heart. 2002 Aug; 88(2):183-4.
  85. Sturdivant JL, Pereira N. Sudden cardiac death in idiopathic dilated cardiomyopathy. J S C Med Assoc. 2001 Oct; 97(10):431-4.
    View PubMed
  86. Kingman A, Pereira NL. Cardiac amyloidosis. J S C Med Assoc. 2001 May; 97(5):201-6.
    View PubMed
  87. Pereira N, Parisi A, Dec GW, Choo J, Hajjar R, Gordon PC. Myocardial stunning in hyperthyroidism. Clin Cardiol. 2000 Apr; 23(4):298-300.
    View PubMed
  88. Pereira NL, Cooper G 4th. Systolic heart failure: practical implementation of standard guidelines. Clin Cornerstone. 2000; 3(2):1-12.
    View PubMed
  89. Pereira N, Klutz WS, Fox RE, Ahn KW, Travin MI. Identification of severe right ventricular dysfunction by technetium-99m-sestamibi gated SPECT imaging. J Nucl Med. 1997 Feb; 38(2):254-6.
    View PubMed